2019 nCOV was initially identified from cultured samples from pneumonia cases using electron microscopy, and reported as a betacoronavirus, similar to MERS-CoV and SARS-CoV. PCR Assays were then developed and the novel virus identified.
The full genome has been shared and is available and WHO, CDC and PHE have guidelines for laboratories. A fully validated assay has yet to be developed but is expected soon,
Full genome: https://www.gisaid.org/
Laboratory guidelines:
Further following resources are available:
|
CDC |
Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Patients Under Investigation (PUIs) for 2019 Novel Coronavirus (2019-nCoV) |
https://www.cdc.gov/coronavirus/2019-nCoV/guidelines-clinical-specimens.html |
|
WHO |
Interim guidance: laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases |
|
|
PHE |
Wuhan novel coronavirus: handling and processing of laboratory specimens |
|
|
ECDC |
Laboratory testing of suspect cases of 2019 nCoV using RT-PCR |
|
|
Public Health Ontario |
Novel Coronavirus (2019-nCoV) Testing
|
Note:
The ECDC advise that infection with 2019-nCoV should be immediately reported to the Early Warning and Response System (EWRS) in accordance with Decision No 1082/2013 on serious cross-border threats to health and to the IHR system in accordance with the International Health Regulations 2005 (IHR).